Sunil Srivastava

989 total citations · 1 hit paper
16 papers, 430 citations indexed

About

Sunil Srivastava is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Sunil Srivastava has authored 16 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 7 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Sunil Srivastava's work include Retinal Diseases and Treatments (10 papers), Retinal Imaging and Analysis (6 papers) and Retinal and Optic Conditions (5 papers). Sunil Srivastava is often cited by papers focused on Retinal Diseases and Treatments (10 papers), Retinal Imaging and Analysis (6 papers) and Retinal and Optic Conditions (5 papers). Sunil Srivastava collaborates with scholars based in United States, Switzerland and India. Sunil Srivastava's co-authors include Peter K. Kaiser, Ivana K. Kim, Jean‐François Korobelnik, Glenn J. Jaffe, Jeffrey S. Heier, Thomas A. Albini, Jordi Monés, Timothy G. Murray, Christian Pruente and Frank G. Holz and has published in prestigious journals such as Scientific Reports, Ophthalmology and The Journal of Pediatrics.

In The Last Decade

Sunil Srivastava

12 papers receiving 408 citations

Hit Papers

Risk of Inflammation, Retinal Vasculitis, and Retinal Occ... 2020 2026 2022 2024 2020 50 100 150 200

Peers

Sunil Srivastava
Sunil Srivastava
Citations per year, relative to Sunil Srivastava Sunil Srivastava (= 1×) peers Mohammad Hossein Jabbarpoor Bonyadi

Countries citing papers authored by Sunil Srivastava

Since Specialization
Citations

This map shows the geographic impact of Sunil Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Srivastava more than expected).

Fields of papers citing papers by Sunil Srivastava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunil Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Srivastava. The network helps show where Sunil Srivastava may publish in the future.

Co-authorship network of co-authors of Sunil Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of Sunil Srivastava. A scholar is included among the top collaborators of Sunil Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunil Srivastava. Sunil Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mizuno, Yoshiko, et al.. (2025). Screening for Retinal Ischemic Perivascular Lesions in Patients Undergoing Cardiovascular Assessment. Ophthalmology Retina. 10(3). 344–352. 1 indexed citations
2.
Srivastava, Sunil, Peter K. Kaiser, Ananth Sastry, et al.. (2025). Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular Edema. Journal of VitreoRetinal Diseases. 10(1). 74–82.
5.
Monés, Jordi, Sunil Srivastava, Glenn J. Jaffe, et al.. (2020). Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab. Ophthalmology. 128(7). 1050–1059. 238 indexed citations breakdown →
6.
Conti, Felipe F., Fabiana Q. Silva, Sunil Srivastava, et al.. (2018). 36-Month Evaluation of Intravitreous Aflibercept Injection for Wet Age-Related Macular Degeneration in Patients Previously Treated With Ranibizumab or Bevacizumab. Ophthalmic surgery, lasers & imaging retina. 49(3). 179–185. 2 indexed citations
7.
Li, Ang, Felipe F. Conti, Fabiana Q. Silva, et al.. (2017). Long-Term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti–Vascular Endothelial Growth Factor. Ophthalmology Retina. 2(6). 550–557. 11 indexed citations
8.
Ahmad, Baseer, et al.. (2017). MELANOCYTOMA OR JUXTAPAPILLARY MELANOMA?. Retinal Cases & Brief Reports. 13(1). 15–17. 3 indexed citations
9.
Silva, Fabiana Q., Sunil Srivastava, Justis P. Ehlers, et al.. (2016). A 24-Month Evaluation of Aflibercept for Wet Age-Related Macular Degeneration in Patients Previously Receiving Ranibizumab or Bevacizumab. Ophthalmology Retina. 1(2). 111–117. 1 indexed citations
10.
Dhoot, Dilsher S., David Xu, & Sunil Srivastava. (2013). High-Powered Laser Pointer Injury Resulting in Macular Hole Formation. The Journal of Pediatrics. 164(3). 668–668.e1. 18 indexed citations
11.
Stewart, Jay M., Sunil Srivastava, Anne E. Fung, et al.. (2010). Bacterial Contamination of Needles Used for Intravitreal Injections: A Prospective, Multicenter Study. Ocular Immunology and Inflammation. 19(1). 32–38. 23 indexed citations
12.
Kim, Stephen J., Thomas M. Aaberg, Sunil Srivastava, et al.. (2009). VISUAL OUTCOMES AND INCIDENCE OF RECURRENT VITREOUS HEMORRHAGE AFTER VITRECTOMY IN DIABETIC EYES PRETREATED WITH BEVACIZUMAB (AVASTIN). Retina. 29(7). 926–931. 56 indexed citations
14.
15.
Srivastava, Sunil, et al.. (2000). Expression of suicidal intent in depressives.. PubMed. 42(2). 184–7. 8 indexed citations
16.
Srivastava, Sunil, T. Tetsuka, Dorit Daphna-Iken, & Aubrey R. Morrison. (1994). IL-1 beta stabilizes COX II mRNA in renal mesangial cells: role of 3'-untranslated region. American Journal of Physiology-Renal Physiology. 267(3). F504–F508. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026